drug-biomarkercombinationtowarrantfurtherinvestigation.The studywillbeopenatallECMCsandwillbecarriedoutundera singleclinicaltrialprotocolandregulatorysubmission.Thestudy isadaptiveallowingrapidincorporationofnewbiomarker/drug combinationsviasubstantialamendment. Results:AllarmsincorporatecomprehensivectDNAanalysis, supplemented...